Novel host restriction factors implicated in HIV-1 replication
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Human immunodeficiency virus-1 (HIV-1) is known to interact with multiple host cellular proteins during its replication in the target cell. While many of these host cellular proteins facilitate viral replication, a number of them are reported to inhibit HIV-1 replication at various stages of its life cycle. These host cellular proteins, which are known as restriction factors, constitute an integral part of the host's first line of defence against the viral pathogen. Since the discovery of apolipoprotein B mRNA-editing enzyme 3G (APOBEC3G) as an HIV-1 restriction factor, several human proteins have been identified that exhibit anti-HIV-1 restriction. While each restriction factor employs a distinct mechanism of inhibition, the HIV-1 virus has equally evolved complex counter strategies to neutralize their inhibitory effect. APOBEC3G, tetherin, sterile alpha motif and histidine-aspartate domain 1 (SAMHD1), and trim-5α are some of the best known HIV-1 restriction factors that have been studied in great detail. Recently, six novel restriction factors were discovered that exhibit significant antiviral activity: endoplasmic reticulum α1,2-mannosidase I (ERManI), translocator protein (TSPO), guanylate-binding protein 5 (GBP5), serine incorporator (SERINC3/5) and zinc-finger antiviral protein (ZAP). The focus of this review is to discuss the antiviral mechanism of action of these six restriction factors and provide insights into the probable counter-evasion strategies employed by the HIV-1 virus. The recent discovery of new restriction factors substantiates the complex host-pathogen interactions occurring during HIV-1 pathogenesis and makes it imperative that further investigations are conducted to elucidate the molecular basis of HIV-1 replication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of HIV-1 infection with early antiretroviral therapy.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105243 · Cited by 6,873
Roles of N-Linked Glycans in the Endoplasmic Reticulum
Helenius, A., & Aebi, M. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073752 · Cited by 2,037 · cited 1×
“Initially, nascent polypeptide chains are co-translationally transferred to the endoplasmic reticulum (ER) lumen, where they are covalently attached to preassembled oligosaccharides (Glc3Man9GlcNAc2) at Asn residues present in the consensus Asn-X-(Ser/Thr) motifs [22, 23].”
BackgroundReplication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure
Ho, Y.-C., Shan, L., Hosmane, N. N., Wang, J., Laskey, S. B., Rosenbloom, D. I. S., Lai, J., Blankson, J. N., Siliciano, J. D., & Siliciano, R. F. (2013) · Cell · doi:10.1016/j.cell.2013.09.020 · Cited by 1,405 · cited 1×
“11 On: Wed, 05 Dec 2018 01:51:36 drug-resistant variants and a tendency to remain latent in the host genome [6].”
BackgroundSpecific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding
Braestrup, C., & Squires, R. F. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.9.3805 · Cited by 1,264
McEnery, M. W., Snowman, A. M., Trifiletti, R. R., & Snyder, S. H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3170 · Cited by 708
Sawyer, S. L., Wu, L. I., Emerman, M., & Malik, H. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409853102 · Cited by 688
Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G
Sawyer, S. L., Emerman, M., & Malik, H. S. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020275 · Cited by 485
CG dinucleotide suppression enables antiviral defence targeting non-self RNA
Takata, M. A., Gonçalves-Carneiro, D., Zang, T. M., Soll, S. J., York, A., Blanco-Melo, D., & Bieniasz, P. D. (2017) · Nature · doi:10.1038/nature24039 · Cited by 398 · cited 1×
“[113], which suggested that ZAP binds directly to HIV-1 RNA sequences containing the CG dinucleotide and inhibits HIV-1 replication [113].”
BackgroundKrueger, K. E., & Papadopoulos, V. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77217-7 · Cited by 345
Li, H., Yao, Z.-X., Degenhardt, B., Teper, G., & Papadopoulos, V. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1267 · Cited by 317 · cited 1×
“TSPO is localized on the outer mitochondrial membrane [38] and contains a C-terminal cholesterol interaction sequence, which mediates the import of cholesterol from the outer to the inner mitochondrial membrane [39].”
BackgroundInduction of IL-17 and nonclassical T-cell activation by HIV-Tat protein
Johnson, T. P., Patel, K., Johnson, K. R., Maric, D., Calabresi, P. A., Hasbun, R., & Nath, A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308673110 · Cited by 265
Serinc, an activity-regulated protein family, incorporates serine into membrane lipid synthesis
Inuzuka, M., Hayakawa, M., & Ingi, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505712200 · Cited by 198
Structural Basis for Catalysis and Inhibition ofN-Glycan Processing Class I α1,2-Mannosidases
Vallée, F., Karaveg, K., Herscovics, A., Moremen, K. W., & Howell, P. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006927200 · Cited by 152 · cited 1×
“Structurally, the catalytic domain of ERManI contains an (aa) 7-barrel composed of 14 consecutive helices, of which Glu-330, Asp-463 and Glu-599 act as the catalytic residues [54, 55].”
BackgroundRegulation of the protein disulfide proteome by mitochondria in mammalian cells
Yang, Y., Song, Y., & Loscalzo, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702027104 · Cited by 129
Expression profile of host restriction factors in HIV-1 elite controllers
Abdel-Mohsen, M., Raposo, R. A. S., Deng, X., Li, M., Liegler, T., Sinclair, E., Salama, M. S., Ghanem, H. E.-D. A., Hoh, R., Wong, J. K., et al. (2013) · Retrovirology · doi:10.1186/1742-4690-10-106 · Cited by 96
Vpr Overcomes Macrophage-Specific Restriction of HIV-1 Env Expression and Virion Production
Mashiba, M., Collins, D. R., Terry, V. H., & Collins, K. L. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.10.014 · Cited by 71
Cited by
Interplay between SARS-CoV-2 and the type I interferon response
Sa Ribero, M., Jouvenet, N., Dreux, M., & Nisole, S. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1008737 · Cited by 443
Nchioua, R., Kmiec, D., Müller, J. A., Conzelmann, C., Groß, R., Swanson, C. M., Neil, S. J. D., Stenger, S., Sauter, D., Münch, J., et al. (2020) · mBio · doi:10.1128/mbio.01930-20 · Cited by 146
Carter, V., LaCava, J., Taylor, M. S., Liang, S. Y., Mustelin, C., Ukadike, K. C., Bengtsson, A., Lood, C., & Mustelin, T. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41054 · Cited by 41
Metadata
- Authors
- Ghimire, D., Rai, M., & Gaur, R.
- Venue
- Journal of General Virology
- Publisher
- Microbiology Society
- Published
- 2018-04-01
- Volume
- 99
- Issue
- 4
- Pages
- 435-446
- ISSN
- 0022-1317 (ISSN-L)
- 1465-2099
- OpenAlex
- W2788714776
- Cited by
- 76
- References
- 16
- FWCI
- 4.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.